Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia.

about

Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia.

Item

http://www.wikidata.org/entity/Q41042591

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prevalence of drug resistance ...... th HIV-1 CRF06_cpx in Estonia.

@en

type

Item

label

Prevalence of drug resistance ...... th HIV-1 CRF06_cpx in Estonia.

@en

prefLabel

Prevalence of drug resistance ...... th HIV-1 CRF06_cpx in Estonia.

@en

P1476

Prevalence of drug resistance ...... th HIV-1 CRF06_cpx in Estonia.

@en

P2093

Tõnu Margus

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

Estonia at the threshold of the fourth decade of the AIDS era in Europe

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

Are subtype differences important in HIV drug resistance?

Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.

P304

448-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24361

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26291050

http://www.w3.org/2001/XMLSchema#string

Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia.

about

Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698